Primary |
Computerised Tomogram |
20.4% |
Angiogram Cerebral |
13.3% |
Arteriogram Carotid |
11.0% |
Carotid Artery Stent Insertion |
11.0% |
Angiogram |
7.7% |
Catheterisation Cardiac |
3.3% |
Chest X-ray Abnormal |
3.3% |
Joint Dislocation |
3.3% |
Abdominal Mass |
2.8% |
Abdominal Pain |
2.8% |
Chest Pain |
2.8% |
Hypertension |
2.8% |
Angioplasty |
2.2% |
Arteriogram |
2.2% |
Dyspnoea |
2.2% |
Peripheral Vascular Disorder |
2.2% |
Aneurysm |
1.7% |
Arthrogram |
1.7% |
Nuclear Magnetic Resonance Imaging |
1.7% |
Pain |
1.7% |
|
Nephropathy Toxic |
22.3% |
Anaphylactic Shock |
8.5% |
Vomiting |
8.5% |
Hypersensitivity |
6.4% |
Loss Of Consciousness |
6.4% |
Urticaria |
5.3% |
Anaphylactic Reaction |
4.3% |
Drug Administration Error |
4.3% |
Nausea |
4.3% |
Respiratory Depression |
4.3% |
Arteriospasm Coronary |
3.2% |
Dyspnoea |
3.2% |
Injection Site Infection |
3.2% |
Renal Failure |
3.2% |
Bronchospasm |
2.1% |
Cardiac Arrest |
2.1% |
Cardio-respiratory Arrest |
2.1% |
Cerebral Infarction |
2.1% |
Cerebrovascular Accident |
2.1% |
Extravasation |
2.1% |
|
Secondary |
Angiogram Cerebral |
11.3% |
Computerised Tomogram |
10.3% |
Abdominal Pain |
8.5% |
Arteriogram Carotid |
8.5% |
Carotid Artery Stent Insertion |
8.5% |
Angiogram |
7.4% |
Pain |
7.4% |
Musculoskeletal Pain |
6.4% |
Non-small Cell Lung Cancer |
4.3% |
Hypertension |
3.5% |
Dyspnoea |
3.2% |
Arteriogram |
2.8% |
Peripheral Vascular Disorder |
2.8% |
Angioplasty |
2.1% |
Chest Pain |
2.1% |
Chest X-ray Abnormal |
2.1% |
Constipation |
2.1% |
Cough |
2.1% |
Joint Dislocation |
2.1% |
Lumbar Hernia |
2.1% |
|
Nephropathy Toxic |
25.0% |
Anaphylactic Shock |
10.0% |
Drug Administration Error |
8.0% |
Loss Of Consciousness |
6.0% |
Anaphylactic Reaction |
5.0% |
Vomiting |
5.0% |
Cardiac Arrest |
4.0% |
Multi-organ Failure |
4.0% |
Respiratory Depression |
4.0% |
Cerebrovascular Accident |
3.0% |
Hypersensitivity |
3.0% |
Injection Site Infection |
3.0% |
Nausea |
3.0% |
Renal Failure |
3.0% |
Renal Failure Acute |
3.0% |
Thrombocytopenia |
3.0% |
Abasia |
2.0% |
Bronchospasm |
2.0% |
Cerebral Infarction |
2.0% |
Dyspnoea |
2.0% |
|
Concomitant |
Product Used For Unknown Indication |
36.1% |
Nuclear Magnetic Resonance Imaging |
18.4% |
Angiogram |
8.2% |
Computerised Tomogram |
6.7% |
Coronary Artery Bypass |
4.6% |
Fistulogram |
4.2% |
Nuclear Magnetic Resonance Imaging Brain |
4.2% |
Venogram |
3.5% |
Catheterisation Cardiac |
3.4% |
Computerised Tomogram Head |
3.2% |
Hypertension |
1.2% |
Aortic Valve Replacement |
1.1% |
Pain |
1.1% |
Prophylaxis Against Transplant Rejection |
1.1% |
Premedication |
0.9% |
Cardiac Stress Test |
0.5% |
Echocardiogram |
0.5% |
Computerised Tomogram Abdomen |
0.4% |
Hypoparathyroidism |
0.4% |
Mitral Valve Replacement |
0.4% |
|
Injury |
9.3% |
Discomfort |
7.9% |
Dry Skin |
7.9% |
General Physical Health Deterioration |
7.9% |
Oedema Peripheral |
7.9% |
Fear Of Death |
6.4% |
Skin Tightness |
6.4% |
Walking Aid User |
6.4% |
Unevaluable Event |
5.7% |
Anxiety |
4.3% |
Fear |
4.3% |
Renal Injury |
4.3% |
Nephrogenic Fibrosing Dermopathy |
3.6% |
Stress |
3.6% |
Cerebral Infarction |
2.9% |
Renal Failure |
2.9% |
Anhedonia |
2.1% |
Nephrogenic Systemic Fibrosis |
2.1% |
Renal Failure Acute |
2.1% |
Spinal Cord Infarction |
2.1% |
|